Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-07-26
2005-07-26
Shameem, Golam M M (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C548S953000, C546S184000, C546S208000
Reexamination Certificate
active
06921758
ABSTRACT:
There is provided amino acid derivatives of formula I,wherein p, q, R1, R2, R3, R4, Y, n and B have meanings given in the description which are useful as competitive inhibitors of trypsin-like proteases, such as thrombin, and in particular in the treatment of conditions where inhibition of thrombin is required (e.g. thrombosis) or as anticoagulants.
REFERENCES:
patent: 4346078 (1982-08-01), Bajusz et al.
patent: 5561146 (1996-10-01), Kim et al.
patent: 5583146 (1996-12-01), Kimball et al.
patent: 5614499 (1997-03-01), Bylund et al.
patent: 5629324 (1997-05-01), Vacca et al.
patent: 5705487 (1998-01-01), Schacht et al.
patent: 5707966 (1998-01-01), Schacht et al.
patent: 5710130 (1998-01-01), Schacht et al.
patent: 5723444 (1998-03-01), Antonsson et al.
patent: 5726159 (1998-03-01), Schacht et al.
patent: 5741792 (1998-04-01), Kimball et al.
patent: 5741799 (1998-04-01), Kimball et al.
patent: 5744487 (1998-04-01), Ohshima et al.
patent: 5780631 (1998-07-01), Antonsson et al.
patent: 5783563 (1998-07-01), Antonsson et al.
patent: 6051568 (2000-04-01), Gustafsson et al.
patent: 6255301 (2001-07-01), Gustafsson et al.
patent: 6337343 (2002-01-01), Gustafsson et al.
patent: 6617320 (2003-09-01), Gustafsson et al.
patent: 0 364 344 (1980-04-01), None
patent: 0 185 390 (1986-06-01), None
patent: 0 195 212 (1986-09-01), None
patent: 0 293 881 (1988-12-01), None
patent: 0 362 002 (1990-04-01), None
patent: 0 364 344 (1990-04-01), None
patent: 0 468 231 (1991-01-01), None
patent: 0 468 231 (1992-01-01), None
patent: 0 526 877 (1993-02-01), None
patent: 0 526 877 (1993-02-01), None
patent: 0 530 167 (1993-03-01), None
patent: 0 542 525 (1993-05-01), None
patent: 0 559 046 (1993-09-01), None
patent: 0 601 459 (1994-06-01), None
patent: 0 641 779 (1995-03-01), None
patent: 0 648 780 (1995-04-01), None
patent: 0 669 317 (1995-08-01), None
patent: 0 686 642 (1995-12-01), None
patent: WO 93/11152 (1993-06-01), None
patent: WO 93/18060 (1993-09-01), None
patent: 94/29336 (1994-12-01), None
patent: WO 95/01168 (1995-01-01), None
patent: WO 95/23609 (1995-09-01), None
patent: 95/35309 (1995-12-01), None
patent: WO 96/03374 (1996-02-01), None
patent: WO 96/25426 (1996-08-01), None
patent: WO 96/32110 (1996-10-01), None
G. Claeson, “Synthetic peptides and peptidomimetics . . . ” Blood Coagulation & Fibrinolysis, 5, pp. 411-436.
B. Blomback et al., “Synthetic peptides with anticoagulant and Vasodilating . . . ” Scand. J. Clin. Lab. Invest. Suppl 107, (1969) pp. 59-64.
Labes et al, “Hansch-Analyse der Hemmwirkung von 3- und 4-substituierten Benzamidinen gegenuber Thrombin, Plasmin and Trypsin,” Pharmazie, vol. 34, No. 10 (1979).
Markwardt et al, “Synthetic Low Molecular Weight Inhibitors of Serum Kallikrein, ”Biochemical Pharmacology, vol. 23, pp. 2247-2256 (1974).
Gustafsson David
Nyström Jan-Erik
AstraZeneca AB
Nixon & Vanderhye
Shameem Golam M M
LandOfFree
Amino acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amino acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amino acid derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3388605